Dafna Capital Management LLC Sage Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

$389 Million
Q3 2024

A detailed history of Dafna Capital Management LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 108,200 shares of SAGE stock, worth $551,820. This represents 0.2% of its overall portfolio holdings.

Number of Shares

108,200

Previous 116,200 6.88%

Holding current value

$551,820

Previous $1.26 Million 38.14%

% of portfolio

0.2%

Previous 0.32%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$7.02 - $13.08 $56,160 - $104,640	-8,000 Reduced 6.88%	108,200 $780,000
Q2 2024 Aug 14, 2024	BUY	$10.58 - $17.9 $1.23 Million - $2.08 Million	116,200 New	116,200 $1.26 Million
Q4 2023 Feb 14, 2024	BUY	$17.1 - $22.26 $4.19 Million - $5.45 Million	245,000 New	245,000 $5.31 Million
Q3 2021 Nov 15, 2021	BUY	$40.26 - $57.37 $402,600 - $573,700	10,000 Added 5.87%	180,306 $7.99 Million
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $603,680 - $872,190	-11,000 Reduced 6.07%	170,306 $9.68 Million
Q4 2020 Feb 16, 2021	BUY	$58.41 - $89.06 $1.34 Million - $2.05 Million	23,000 Added 14.53%	181,306 $15.7 Million
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $287,910 - $437,150	-7,000 Reduced 4.23%	158,306 $9.68 Million
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $1.06 Million - $3.13 Million	40,500 Added 32.45%	165,306 $4.75 Million
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $140,290 - $189,960	1,000 Added 0.81%	124,806 $17.5 Million
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $1.74 Million - $3.19 Million	19,500 Added 18.69%	123,806 $19.7 Million
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $409,700 - $698,550	5,000 Added 5.03%	104,306 $9.99 Million
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $456,591 - $558,846	3,306 Added 3.44%	99,306 $14 Million
Q2 2018 Aug 13, 2018	BUY	$140.36 - $175.76 $280,720 - $351,520	2,000 Added 2.13%	96,000 $15 Million
Q1 2018 May 15, 2018	BUY	$152.15 - $192.33 $9.92 Million - $12.5 Million	65,200 Added 226.39%	94,000 $15.1 Million
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $1.75 Million - $4.82 Million	28,800	28,800 $4.74 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $303M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Sage Therapeutics, Inc. Transaction History